Notice of Intent to Publish DaCCoTA Feasibility, Ready-to-Go, and Community Engagement Pilot Grants

The Dakota Cancer Collaborative on Translational Activity (DaCCoTA) will soon be reissuing three RFAs for the Feasibility, Ready-to-Go, and Community Engagement pilot grants.

The Feasibility Award is intended to provide support to allow a clinician/non-clinician team to form around a novel cancer-related hypothesis. Applications can consider the multilevel manifestations of cancer (e.g., neurological, psychiatric), demographic risks, and social impact. Applications should focus on T2-T4 translational research, although T1 studies will be considered if there is a clear plan to progress to T2-T4. The award’s primary goal is to allow a team to form and connect with the CTR Biostatistics, Epidemiology, and Research Design Core; Clinical Research Resources and Facilities Core; Community Engagement and Outreach Core; and Pilot Projects Program to generate competitive proposals for the CTR Ready-to-Go Pilot Award mechanism.

The Ready-to-Go Award is intended for projects with existing significant preliminary data in support of a novel clinical/translational cancer-related hypothesis. Applications can consider the multilevel manifestations of cancer (e.g., neurological, psychiatric), demographic risks, and social impact. Applications will focus on T2- T4 translational research, although T1 studies will be considered if there is a clear plan to progress to T2-T4. Successful completion of these proposals should lead to a collaborative extramural grant submission and peer-reviewed manuscript submission.

The Community Engagement Award is intended for projects addressing priority areas as determined by key stakeholder groups, including the American Cancer Society, Community Health Association of the Dakotas, N.D. Department of Health, and the Great Plains Tribal Chairmen’s Health Board. Proposals should address cancer disparities in:

• Colorectal cancer screening, stage and diagnosis, treatment, and mortality,
• Tobacco-related cancers (Lung, CRC, etc.), or
• Breast cancer screening, stage at diagnosis, and mortality.

Pilot awards should focus on compiling existing data and published manuscripts or propose an original study regarding these areas of cancer disparities in the Dakotas. Applications can consider the multilevel manifestations of cancer (e.g. neurological, psychiatric), demographic risks, and social impact. Applications will focus on T2-T4 translational research, although T1 studies will be considered if there is a clear plan to progress to T2-T4. Successful completion of these proposals should lead to an extramural grant submission and peer-reviewed manuscript submission.

Applications are not being solicited at this time. The estimated publication date of the funding opportunity announcement is Jan. 6, 2020. Please visit the collaborative online at https://med.und.edu/daccota/ for more information. Please direct all inquiries to jessica.craig@und.edu.